Advertisement

Osteoporosis International

, Volume 23, Issue 3, pp 957–962 | Cite as

Ankle fractures do not predict osteoporotic fractures in women with or without diabetes

  • J. M. Pritchard
  • L. M. Giangregorio
  • G. Ioannidis
  • A. Papaioannou
  • J. D. Adachi
  • W. D. Leslie
Original Article

Abstract

Summary

It is not clear whether ankle fractures predict future osteoporotic fractures in women, and whether diabetes influences this relationship. We found that a prior ankle fracture does not predict subsequent osteoporotic fractures in women with or without diabetes.

Introduction

We aimed to determine: (1) whether a prior ankle fracture was a risk factor for a subsequent major osteoporotic fracture in older women; (2) whether this risk was modified by the presence of diabetes; (3) the risk factors for ankle fracture in older women.

Methods

We identified 3,054 women age 50 years and older with diabetes and 9,151 matched controls using the Manitoba Bone Density Program database. Multivariable regression models were used to examine factors associated with prior ankle fracture, and the importance of prior ankle fracture as a predictor of subsequent major osteoporotic fracture during a mean 4.8 years of observation.

Results

A prior ankle fracture was not a significant predictor of subsequent major osteoporotic fracture for women with diabetes (hazard ratio [HR] 1.13; 95% confidence interval [CI], 0.68–1.83; p = 0.623) or women without diabetes (HR 1.16; 95% CI, 0.79–1.71; p = 0.460), and there was no interaction between diabetes and ankle fracture after pooling all women in the cohort (p = 0.971). The presence of diabetes was not independently associated with prior ankle fracture (adjusted odds ratio [OR] 1.14 [95% CI, 0.93–1.38], p = 0.200), whereas higher body mass index (adjusted OR 1.04 per standard deviation increase [95% CI, 1.03–1.06], p < 0.001), previous major osteoporotic fracture (adjusted OR 1.40 [95% CI, 1.13–1.75], p = 0.002), and multiple comorbidities (>6 ambulatory diagnostic groups) (adjusted OR 1.81 [95% CI, 1.40–2.36], p < 0.001) were related to prior ankle fracture.

Conclusions

Ankle fracture was not a significant predictor of major osteoporotic fracture in women, and a diagnosis of diabetes did not influence the relationship.

Keywords

Ankle fracture Diabetes Osteoporosis Osteoporotic fracture Risk factor 

Notes

Acknowledgements

We are indebted to Manitoba Health for providing data (HIPC File No. 2008/2009–08). The results and conclusions are those of the authors, and no official endorsement by Manitoba Health is intended or should be inferred. This article has been reviewed and approved by the members of the Manitoba Bone Density Program Committee.

Conflicts of interest

W.D. Leslie has served on the advisory board for Amgen, Genzyme and Novartis; has received unrestricted research grants from Amgen, Genzyme, Merck Frosst, Proctor & Gamble and Sanofi-Aventis; has received speaker fees from Amgen and Merck Frosst; has received travel funds from Genzyme.

J.D. Adachi has served as a consultant and speaker for Amgen, Astra Zeneca, Bristol-Myers Squibb, Eli Lilly, GSK, Merck Frosst, Novartis, Nycomed, Pfizer, Procter & Gamble, Roche, Sanofi Aventis, Servier and Wyeth; has received clinical trials grants from Amgen, Bristol-Myers Squibb, Eli Lilly, GSK, Merck Frosst; Novartis, Pfizer, Procter & Gamble, Sanofi Aventis, Roche and Wyeth.

A. Papaioannou has served on the advisory board for Amgen, Eli Lilly, Merck Frosst, Proctor & Gamble and Novartis; has consulted for Amgen, Aventis Pharma, Eli Lilly, Lundbeck Canada Inc., Merck Frosst, Novartis, Proctor & Gamble, Servier, Warner Chillcott and Wyeth-Ayerst; has received unrestricted research grants from Amgen, Eli Lilly, Merck Frosst, Proctor & Gamble and Sanofi-Aventis; has received clinical trial grants from Novartis and Phizer, has received a research grant from the Ontario Ministry of Health and Long-Term Care; has served as a member of the Continuing Medical Education Steering Committee of the Ontario College of Family Physicians.

J.M. Pritchard, L.M. Giangregorio and G. Ioannidis have no conflict of interest to declare.

References

  1. 1.
    Kanis JA, Oden A, Johnell O, Jonsson B, De Laet C, Dawson A (2001) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 12:417–427PubMedCrossRefGoogle Scholar
  2. 2.
    Johnell O, Kanis JA (2005) Epidemiology of osteoporotic fractures. Osteoporos Int 16(Suppl 2):S3–S7PubMedCrossRefGoogle Scholar
  3. 3.
    Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, Eisman J, Fujiwara S, Garnero P, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A (2004) A meta-analysis of previous fracture and sub-sequent fracture risk. Bone 35:375–382PubMedCrossRefGoogle Scholar
  4. 4.
    Wiktorowicz MEGR, Papaioannou A, Adachi JD, Papadimitropoulos E (2001) Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int 12:271–278PubMedCrossRefGoogle Scholar
  5. 5.
    Papaioannou A, Kennedy C, Ioannidis G, Sawka A, Hopman WM, Pickard L, Brown JP, Josse RG, Kaiser S, Anastassiades T, Goltzman D, Papadimitropoulous M, Tenenhouse A, Prior JC, Olszynski WP, Adachi JD, for the CaMos Study Group (2009) The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporos Int 20:703–714PubMedCrossRefGoogle Scholar
  6. 6.
    Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385–397PubMedCrossRefGoogle Scholar
  7. 7.
    Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD (2010) Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 182:1864–1873PubMedCrossRefGoogle Scholar
  8. 8.
    Hamdy RC, Baim S, Broy SB, Lewiecki EM, Morgan SL, Tanner SB, Williamson HF (2010) Algorithm for the management of osteoporosis. South Med J 103(10):1009–1015PubMedCrossRefGoogle Scholar
  9. 9.
    Ho PY, Tang N, Law SW, Tsui HF, Lam TP, Leung KS (2006) A prospective case-control study of ankle fracture in postmenopausal women. Hong Kong Med J 12(3):208–211PubMedGoogle Scholar
  10. 10.
    Jones KB, Maiers-Yelden KA, Marsh JL, Zimmerman MB, Estin M, Saltzman CL (2005) Ankle fractures in patients with diabetes mellitus. J Bone Jt Surg Br 87(4):489–495CrossRefGoogle Scholar
  11. 11.
    Hasselman CT, Vogt MT, Stone KL, Cauley JA, Conti SF (2003) Foot and ankle fractures in elderly white women. Incidence and risk factors. J Bone Jt Surg Am 85-A(5):820–824Google Scholar
  12. 12.
    Eastell R, Reid DM, Compston J, Cooper C, Fogelman I, Francis RM, Hay SM, Hosking DJ, Purdie DW, Ralston SH, Reeve J, Russell RG, Stevenson JC (2001) Secondary prevention of osteoporosis: when should a non-vertebral fracture be a trigger for action? Q J Med 94(11):575–597CrossRefGoogle Scholar
  13. 13.
    Schwartz AV, Sellmeyer DE, Ensrud KE, Cauley JA, Tabor HK, Schreiner PJ, Jamal SA, Black DM, Cummings SR (2001) Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 86(1):32–38PubMedCrossRefGoogle Scholar
  14. 14.
    Melton LJ, Leibson CL, Achenbach SJ, Therneau TM, Khosla S (2008) Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res 23(8):1334–1342PubMedCrossRefGoogle Scholar
  15. 15.
    Bonds DE, Larson JC, Schwartz AV, Strotmeyer ES, Robbins J, Rodriguez BL, Johnson KC, Margolis KL (2006) Risk of fracture in women with type 2 diabetes: the Women’s Health Initiative Observational Study. J Clin Endocrinol Metab 91(9):3404–3410PubMedCrossRefGoogle Scholar
  16. 16.
    Lix LM, Yohendran MS, Leslie WD, Shaw SY, Baumgartner R, Bowman C, Metge C, Gumel A, Hux J, James RC (2008) Using multiple data features improved the validity of osteoporosis case ascertainment from administrative databases. J Clin Epidemiol 61:1250–1260PubMedCrossRefGoogle Scholar
  17. 17.
    Roos LL, Mustard CA, Nicol JP, McLerran DF, Malenka DJ, Young TK, Cohen MM (1993) Registeries and administrative data: organization and accuracy. Med Care 31:201–212PubMedCrossRefGoogle Scholar
  18. 18.
    Leslie WD, Caetano PA, MacWilliam LR, Finlayson GS (2005) Construction and validation of a population-based bone densitometry database. J Clin Densitom 8(1):25–30PubMedCrossRefGoogle Scholar
  19. 19.
    Blanchard JF, Ludwig S, Wajda A, Dean H, Anderson K, Kendall O (1996) Incidence and prevalence of diabetes in Manitoba. 1986–1991. Diabetes Care 27:1047–1053Google Scholar
  20. 20.
    Giangregorio LM, Leslie WD (2010) Time since prior fracture is a risk modifier for ten year osteoporotic fractures. J Bone Miner Res 25(6):1400–1405PubMedCrossRefGoogle Scholar
  21. 21.
    Leslie WD (2006) The importance of spectrum bias on bone density monitoring in clinical practice. Bone 39:361–368PubMedCrossRefGoogle Scholar
  22. 22.
    Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, Johnston CC Jr, Lindsay R (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8(5):468–489PubMedCrossRefGoogle Scholar
  23. 23.
    Leslie WD, Derksen S, Prior HJ, Lix LM, Metge C, O’Neil J (2006) The interaction of ethnicity and chronic disease as risk factors for osteoporotic fractures: a comparison in Canadian Aboriginals and non-Aboriginals. Osteoporos Int 17(9):1358–1368PubMedCrossRefGoogle Scholar
  24. 24.
    Leslie WDBC, Langsetmo L, Adachi JD, Hanley DA, Ioannidis G, Goltzman D, Papaioannou A, Josse R, Kovacs CS, Olszynski WP, Towheed T, Kaiser SM, Prior J, Jamal S, Kreiger N, Brown JP, the CaMos Research Group (2011) Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: Results from the CaMos and Manitoba BMD cohorts. Osteoporos Int (in press)Google Scholar
  25. 25.
    Watts NB, Lewiecki EM, Miller PD, Baim S (2008) National Osteoporosis Foundation 2008 Clinician’s Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): What they mean to the bone densitometrist and bone technologist. J Clin Densitom 11(4):473–477PubMedCrossRefGoogle Scholar
  26. 26.
    Sharma S, Fraser M, Lovell F, Reece A, McLellan AR (2008) Characteristics of males over 50 years who present with a fracture. J Bone Jt Surg (Br) 90B(1):72–77Google Scholar
  27. 27.
    Langsetmo L, Hanley DA, Kreiger N, Jamal SA, Prior J, Adachi JD, Davison KS, Kovacs C, Anastassiades T, Tenenhouse A, Goltzman D (2008) Geographic variation of bone mineral density and selected risk factors for prediction of incident fracture among Canadians 50 and older. Bone 43(4):672–678PubMedCrossRefGoogle Scholar
  28. 28.
    Gunnes M, Mellstrom D, Johnell O (1998) How well can a previous fracture indicate a new fracture? A questionnaire study of 29,802 postmenopausal women. Acta Orthop Scand 69(5):508–512PubMedCrossRefGoogle Scholar
  29. 29.
    Lauritzen JB, Lund B (1993) Risk of hip fracture after osteoporosis fractures. 451 women with fracture of lumbar spine, olecranon, knee or ankle. Acta Orthop Scand 64(3):297–300PubMedCrossRefGoogle Scholar
  30. 30.
    Center JR, Bliuc D, Nguyen TV, Eisman JA (2007) Risk of subsequent fracture after low-trauma fracture in men and women. JAMA 297(4):387–394PubMedCrossRefGoogle Scholar
  31. 31.
    Valtola A, Honkanen R, Kroger H, Tuppurainen M, Saarikoski S, Alhava E (2002) Lifestyle and other factors predict ankle fractures in perimenopausal women: a population-based prospective cohort study. Bone 30(1):238–242PubMedCrossRefGoogle Scholar
  32. 32.
    Ivers RQ, Cumming RG, Mitchell P, Peduto AJ (2001) Diabetes and risk of fracture: the Blue Mountains Eye Study. Diabetes Care 24(7):1198–1203PubMedCrossRefGoogle Scholar
  33. 33.
    Honkanen R, Tuppurainen M, Kroger H, Alhava E, Saarikoski S (1998) Relationships between risk factors and fractures differ by type of fracture: a population-based study of 12192 perimenopausal women. Osteoporos Int 8:25–31PubMedCrossRefGoogle Scholar
  34. 34.
    Seeley DG, Kelsey J, Jergas M, Nevitt MC (1996) Predictors of ankle and foot fractures in older women. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 11(9):1347–1355PubMedCrossRefGoogle Scholar
  35. 35.
    Evans JMM, MacDonald TM, Leese GP, Ruta DA, Morris AD (2000) Impact of type 1 and type 2 diabetes on patterns and costs of drug prescribing. Diabetes Care 23:770–774PubMedCrossRefGoogle Scholar
  36. 36.
    Nicodemus KK, Folsom AR (2001) Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 24(7):1192–1197PubMedCrossRefGoogle Scholar
  37. 37.
    Meier C, Kraenzlin ME, Bodmer M, Jick SS, Jick H, Meier CR (2008) Use of thiazolidinediones and fracture risk. Arch Intern Med 168(8):820–825PubMedCrossRefGoogle Scholar
  38. 38.
    Loke YK, Singh S, Furberg CD (2009) Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis. CMAJ 180(1):32–39PubMedCrossRefGoogle Scholar
  39. 39.
    Schwartz AV, Sellmeyer DE, Vittinghoff E, Palermo L, Lecka-Czernik B, Feingold KR, Strotmeyer ES, Resnick HE, Carbone L, Beamer BA, Park SW, Lane NE, Harris TB, Cummings SR (2006) Thiazolidinedione use and bone loss in older diabetic adults. J Clin Endocrinol Metab 91(9):3349–3354PubMedCrossRefGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2011

Authors and Affiliations

  • J. M. Pritchard
    • 1
    • 5
  • L. M. Giangregorio
    • 2
  • G. Ioannidis
    • 3
  • A. Papaioannou
    • 3
  • J. D. Adachi
    • 3
  • W. D. Leslie
    • 4
  1. 1.Faculty of Health SciencesMcMaster UniversityHamiltonCanada
  2. 2.Department of KinesiologyUniversity of WaterlooWaterlooCanada
  3. 3.Department of MedicineMcMaster UniversityHamiltonCanada
  4. 4.Department of MedicineUniversity of ManitobaWinnipegCanada
  5. 5.Hamilton Health SciencesSt. Peter’s HospitalHamiltonCanada

Personalised recommendations